- First broadcast of a live operation using the avatera system performing a radical prostatectomy during the DRUS meeting
- AvataraGreg Roche, CEO of medical, will be presenting at the ERUS (EAU Robotic Urology Section) meeting on October 28thth
- Expansion of Avatera into routine clinical use across Europe for urological and gynecological indications underway
JENA, Germany, Oct. 25, 2022 (GLOBE NEWSWIRE) — Avataramedical GmbH, an innovative German medical technology company specializing in robotic, minimally invasive surgery, is pleased to announce that its avatera system, which is in clinical use in several clinics across Europe, is its first live operation during the annual conference of the German Society for Robot-Assisted Urology (DRUS). The radical prostatectomy was performed by Prof. Dr. Evangelos Liatsikos, Director of the Department of Urology, University of Patras (Greece), an experienced urological surgeon and Chair of the European School of Urology, and broadcast live to the DRUS audience in the auditorium.
“I have been using the avatera system for surgeries in our urology department since May and I am very impressed with the reliable results and the well thought-out design. That’s also why I was excited to demonstrate the performance of the system live to a specialist audience. I can say that avatera meets the needs of many surgeons and I believe it can be a valuable addition for many hospitals looking to add surgical robotics to their offerings or expand their current capabilities,” he commented Prof. Dr. Evangelos Liatsikos, Director Department of Urology, University of Patras.
“It was a fascinating event to watch Prof. Liatsikos perform the live operation on the new Avatera, broadcast live from the University of Patras to the audience at the 12th Annual Meeting of the German Society for Urological Robotics in Stuttgart. During the successfully performed radical prostatectomy, the capabilities of the new Avatera machine were beautifully demonstrated,” he added Prof. Dr. med….
